Wave Life Sciences Ltd.

WVE

WVE has 13 disclosed filings on Paydirt over the trailing twelve months from 10 corporate insiders: 2 purchases and 11 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Mar 30 and filed Mar 31. The most active filer was Paul Bolno with 6 filings.

Add to watchlist

Filings, ttm

2 buys · 11 sells

Traders, ttm

10 insiders

Volume, ttmiDollar value disclosed in the window

$98.0M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Mar 30

Filed Mar 30

ADViAverage daily dollar volume

–

not on file

Share price · 12M

$5.99 (-13.3%)

Adjusted for splits and dividends.

Volume by month

Buys $104.9M Sells $26.1M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

PB Paul Bolno President and CEO 6 filings CF Chris Francis See Remarks 5 filings GV Gregory L. Verdine Director 3 filings GP GSK plc 10% owner 2 filings CH Christian O Henry See Remarks 2 filings KM Kyle Moran Chief Financial Officer 2 filings AR Adrian Rawcliffe Director 2 filings TN Tan Aik Na Director 2 filings

Recent filings

Ra Capital Management, L.P.PURCHASE Director $54.6M
8,772,496 sh across 4 lots
Exec Mar 26
Filed Mar 30 · 8:30 PM ET Chris FrancisSALE See Remarks $500K
33,194 sh across 2 lots
Exec Feb 26
Filed Feb 27 · 5:30 PM ET Paul BolnoSALE President and CEO $141K
10,480 sh × $13.45
Exec Feb 9
Filed Feb 11 · 5:30 PM ET Chris FrancisSALE See Remarks $129K
8,080 sh × $15.92
Exec Jan 2
Filed Jan 6 · 5:30 PM ET GSK plcPURCHASE 10% owner $27.9M
1,470,000 sh × $19.00
Exec Dec 11 2025
Filed Dec 15 2025 · 4:32 PM ET Mark CorriganSALE Director $126K
9,600 sh × $13.09
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Kyle MoranSALE Chief Financial Officer $4.1M
260,000 sh across 5 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Chris FrancisSALE See Remarks $6.4M
441,031 sh across 9 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Gregory L. VerdineSALE Director $269K
20,000 sh across 2 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Tan Aik NaSALE Director $1.7M
126,724 sh across 7 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Christian O HenrySALE Director $1.3M
87,000 sh across 3 lots
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Adrian RawcliffeSALE Director $630K
42,000 sh × $15.00
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Adrian RawcliffeSALE Director $109K
16,115 sh × $6.79
Exec Nov 13 2025
Filed Nov 14 2025 · 5:30 PM ET Paul BolnoSALE President and CEO $2.2M
217,351 sh × $10.10
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET Gregory L. VerdineSALE Director $100K
10,000 sh × $10.00
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET Tan Aik NaSALE Director $194K
21,000 sh × $9.25
Exec Aug 15 2025
Filed Aug 19 2025 · 5:30 PM ET Gregory L. VerdineSALE Director $208K
30,000 sh × $6.95
Exec Jun 13 2025
Filed Jun 13 2025 · 5:30 PM ET Christian O HenrySALE Director $103K
10,500 sh × $9.77
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET Paul BolnoSALE President and CEO $1.6M
169,025 sh × $9.57
Exec Mar 7 2025
Filed Mar 7 2025 · 5:30 PM ET Paul BolnoSALE President and CEO $750K
50,000 sh × $15.00
Exec Nov 25 2024
Filed Nov 27 2024 · 5:30 PM ET Paul BolnoSALE President and CEO $734K
51,234 sh × $14.32
Exec Nov 15 2024
Filed Nov 15 2024 · 5:30 PM ET Chris FrancisSALE See Remarks $576K
36,000 sh × $16.00
Exec Nov 8 2024
Filed Nov 13 2024 · 5:30 PM ET Paul BolnoSALE President and CEO $1.4M
90,474 sh × $15.00
Exec Oct 16 2024
Filed Oct 18 2024 · 5:30 PM ET Chris FrancisSALE See Remarks $2.9M
208,836 sh across 4 lots
Exec Oct 16 2024
Filed Oct 18 2024 · 5:30 PM ET GSK plcPURCHASE 10% owner $22.3M
2,791,930 sh × $8.00
Exec Sep 27 2024
Filed Oct 1 2024 · 5:30 PM ET